• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Sprint Bioscience's Upcoming Conferences and Investor Events

SPRINTPress release13.08.2026 klo 13.15

Sprint Bioscience AB (publ) summarizes below the company's upcoming meetings with potential partners and investors during the second half of 2026. The list is subject to change and is available on the company's website.

International Partnering Conferences:
8-9 September 2026
Nordic Life Science Days
https://nlsdays.com/

14-16 September 2026
IPLS, International Partnering in Lifescience Society Annual Conference
Stockholm, Sweden
https://ipls.online/events/

7-9 October 2026
Bio Japan, Yokohama, Japan
https://jcd-expo.jp/en/

9-11 November 2026
BIO-Europe, Cologne, Germany
https://informaconnect.com/bioeurope/

Investor meetings:
1 October 2026
Swiss Nordic Biotech, Zürich, Switzerland
https://www.swissnordicbio.com/

4-5 November 2026
BioStock Life Science Summit. Lund, Sweden
https://biostock.se/en/event/life-science-summit-2026/

Scientific Conference:
18 November 2026
38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Barcelona, Spain
https://event.eortc.org/ena2026/

For more information and to view recorded presentations, please visit:
https://sprintbioscience.com/en/calendar/
https://sprintbioscience.com/en/movie/

For further information, kindly contact:


Johan Emilsson, CEO, Sprint Bioscience
Phone: +46 (8) 411 44 55
Email: johan.emilsson@sprintbioscience.com

About Sprint Bioscience AB (publ)


Sprint Bioscience develops small molecule first-in-class drug programs with a focus on oncology. With a fragment-based drug development method, the company develops drug programs in a time- and resource-efficient manner. The programs enter partnerships through licensing agreements, asset acquisitions, or research collaborations with global pharmaceutical companies during the pre-clinical phase and the company has successfully formed several agreements. The Sprint Bioscience share is listed on the Nasdaq First North Premier Growth Market and trades under the ticker symbol SPRINT. The company is based in Stockholm with operations located in Huddinge. Further information is available on the company website; www.sprintbioscience.com. Certified Advisor is FNCA Sweden AB, www.fnca.se.

Attachments


Sprint Bioscience's Upcoming Conferences and Investor Events